Transurban Group Edges up with Earnings update for FY18

TransurbanGroupEdgesupwithEarningsupdateforFY

Transurban Group (ASX: TCL) revealed its FY18 earnings wherein proportional Toll revenue increased 8.7 per cent to $2,340 Mn in FY18 against FY17 while proportional EBITDA lifted by 10.2 per cent and amounted to $1,796 Mn during the same period. Backed by increased toll price and vehicle numbers, NPAT recorded significant growth of 102 per cent to $485 Mn in FY18 against FY17. As a result, the group declared a half-year distribution of 28.0 cents per share which will be paid on 10 August 2018. This will consist of 25.5 cents per share (cps) distribution from Transurban Holding Trust and a 2.5 cps fully franked dividend from Transurban Holdings. The management has provided FY19 distribution guidance of 59.0 cps that include 2.0 cps fully franked. Moreover, the management committed to paying 59 cents per share if WestConnex bid happens successfully.

The free cash flow coverage recorded growth of 101.4% in FY18 as compared to prior year. Moreover, FY19 free cash flow incorporates TIFIA interest payments and amortization of the M5 and ED debt as well as scheduled capital releases as pre-agreed with state governments.

With this news, the stock edged up 0.924 per cent with the intra-trading volume of more than 2.1 Mn. The stock traded at $12.01 with the market-cap of circa $26.47 Mn as on August 07, 2018 (AEST – 3:30 P.M.).

Dividend Stocks To Buy

The Income available from dividends remains attractive for many investors.

We take a look at the best yields on the market and assess what they say about a company’s prospect.

Sponsored ad by Kalkine

One Thing is certain, though, Australia interest rates are still low, making income difficult to come by and keeping the focus for many investors on high yielding stocks. Kalkine’s team of analysts bought you handpicked report for “Top 25 Dividend Stocks For 2018.”

ASX-relevant Special Reports are published year-round to provide a detailed analysis into an investing opportunity or a potential risk to your portfolio.

Click here to get your free report.


Disclaimer

The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkinemedia.com and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.

Join Our Discussion

Start discussion with value Investors for ASX Stock Market Investment and Opinion.


6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report

LEAVE A REPLY

Please enter your comment!
Please enter your name here